167 related articles for article (PubMed ID: 29956066)
1. Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer.
Sahores A; Figueroa V; May M; Liguori M; Rubstein A; Fuentes C; Jacobsen BM; Elía A; Rojas P; Sequeira GR; Álvarez MM; González P; Gass H; Hewitt S; Molinolo A; Lanari C; Lamb CA
Horm Cancer; 2018 Oct; 9(5):338-348. PubMed ID: 29956066
[TBL] [Abstract][Full Text] [Related]
2. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
Wargon V; Riggio M; Giulianelli S; Sequeira GR; Rojas P; May M; Polo ML; Gorostiaga MA; Jacobsen B; Molinolo A; Novaro V; Lanari C
Int J Cancer; 2015 Jun; 136(11):2680-92. PubMed ID: 25363551
[TBL] [Abstract][Full Text] [Related]
3. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
Rojas PA; May M; Sequeira GR; Elia A; Alvarez M; Martínez P; Gonzalez P; Hewitt S; He X; Perou CM; Molinolo A; Gibbons L; Abba MC; Gass H; Lanari C
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376177
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.
Abascal MF; Elia A; Alvarez M; Pataccini G; Sequeira G; Riggio M; Figueroa V; Lamb CA; Rojas PA; Spengler E; Martínez-Vazquez P; Burruchaga J; Liguori M; Sahores A; Wargon V; Molinolo A; Hewitt S; Lombes M; Sartorius C; Vanzulli SI; Giulianelli S; Lanari C
Int J Cancer; 2022 May; 150(9):1481-1496. PubMed ID: 34935137
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.
Wargon V; Fernandez SV; Goin M; Giulianelli S; Russo J; Lanari C
Breast Cancer Res Treat; 2011 Apr; 126(2):319-32. PubMed ID: 20440553
[TBL] [Abstract][Full Text] [Related]
6. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.
Khan JA; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
PLoS One; 2012; 7(9):e45993. PubMed ID: 23029355
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.
Sequeira G; Vanzulli SI; Rojas P; Lamb C; Colombo L; May M; Molinolo A; Lanari C
Oncotarget; 2014 May; 5(10):3246-60. PubMed ID: 24912774
[TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.
Mote PA; Gompel A; Howe C; Hilton HN; Sestak I; Cuzick J; Dowsett M; Hugol D; Forgez P; Byth K; Graham JD; Clarke CL
Breast Cancer Res Treat; 2015 Jun; 151(2):309-18. PubMed ID: 25917868
[TBL] [Abstract][Full Text] [Related]
10. Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.
Pateetin P; Pisitkun T; McGowan E; Boonyaratanakornkit V
J Steroid Biochem Mol Biol; 2020 Apr; 198():105560. PubMed ID: 31809870
[TBL] [Abstract][Full Text] [Related]
11. Nuclear translocation of fibroblast growth factor-2 (FGF2) is regulated by Karyopherin-β2 and Ran GTPase in human glioblastoma cells.
Wang F; Yang L; Shi L; Li Q; Zhang G; Wu J; Zheng J; Jiao B
Oncotarget; 2015 Aug; 6(25):21468-78. PubMed ID: 26056081
[TBL] [Abstract][Full Text] [Related]
12. The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.
Liao S; Bodmer JR; Azhar M; Newman G; Coffin JD; Doetschman T; Schultz Jel J
J Mol Cell Cardiol; 2010 Jun; 48(6):1245-54. PubMed ID: 20116383
[TBL] [Abstract][Full Text] [Related]
13. Roles of different IRES-dependent FGF2 isoforms in the acquisition of the major aggressive features of human metastatic melanoma.
Andreucci E; Bianchini F; Biagioni A; Del Rosso M; Papucci L; Schiavone N; Magnelli L
J Mol Med (Berl); 2017 Jan; 95(1):97-108. PubMed ID: 27558498
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Progesterone Receptor Isoform Balance in Normal and Neoplastic Breast Cells Modulates the Stem Cell Population.
Recouvreux MS; Diaz Bessone MI; Taruselli A; Todaro L; Lago Huvelle MA; Sampayo RG; Bissell MJ; Simian M
Cells; 2020 Sep; 9(9):. PubMed ID: 32932770
[TBL] [Abstract][Full Text] [Related]
15. Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis.
Sahores A; May M; Sequeira GR; Fuentes C; Jacobsen B; Lanari C; Lamb CA
Curr Cancer Drug Targets; 2018; 18(10):979-987. PubMed ID: 29237381
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
17. High molecular weight FGF2 isoforms demonstrate canonical receptor-mediated activity and support human embryonic stem cell self-renewal.
Kole D; Grella A; Dolivo D; Shumaker L; Hermans W; Dominko T
Stem Cell Res; 2017 May; 21():106-116. PubMed ID: 28433654
[TBL] [Abstract][Full Text] [Related]
18. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.
Mote PA; Bartow S; Tran N; Clarke CL
Breast Cancer Res Treat; 2002 Mar; 72(2):163-72. PubMed ID: 12038707
[TBL] [Abstract][Full Text] [Related]
19. Isoform specificity of progesterone receptor antibodies.
Fabris V; Abascal MF; Giulianelli S; May M; Sequeira GR; Jacobsen B; Lombès M; Han J; Tran L; Molinolo A; Lanari C
J Pathol Clin Res; 2017 Oct; 3(4):227-233. PubMed ID: 29085663
[TBL] [Abstract][Full Text] [Related]
20. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells.
McGowan EM; Clarke CL
Mol Endocrinol; 1999 Oct; 13(10):1657-71. PubMed ID: 10517668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]